The first-year experience of a university hospital laser unit Üniversite hastanesi lazer ünitesi ilk yıl deneyimleri


Creative Commons License

Arica D. A., SELCUK L., YAYLI S., Bayrak S., Bahadir S.

Turkderm Turkish Archives of Dermatology and Venereology, cilt.53, sa.1, ss.7-14, 2019 (Scopus) identifier identifier

Özet

©Telif Hakkı 2019 Deri ve Zührevi Hastalıklar DerneğiBackground and Design: The aim of this study was to evaluate the efficacy and safety of neodymium-doped yttrium aluminum garnet (Nd:YAG) laser and intense pulsed light (IPL) systems, and the variety of indications involved. Materials and Methods: First-year treatments in our clinic were evaluated retrospectively. Results were classified according to improvement rates: <25% as mild improvement; 25-75% as moderate improvement and >75% as excellent improvement. Results: One hundred thirty-three patients aged 3-79 years (mean: 35.91) with 14 different indications were treated. Pigmented lesions were treated with IPL, and vascular lesions with IPL and/or Nd:YAG. Combined therapy with IPL and Nd:YAG at two-week intervals resulted in excellent improvement in 70.21% of vascular lesions (34 rosacea, 8 nevus flammeus, and 5 hemangioma), and moderate improvement in the rest. Telangiectasia and angiomatous lesions exhibited excellent improvement in 93.65% of patients with Nd:YAG, and moderate improvement in the rest. IPL resulted in excellent improvement in 78.49% of cases of solar lentigo, and moderate improvement in the rest. Moderate improvement was observed in 66.67% of patients with melasma using IPL, and mild improvement in the rest. Pain scores were significantly lower with Nd:YAG than IPL (p<0.05). Complications related to treatment were observed in 3 patients (vesicles in two patients and atrophic scar in 1), all of which developed after Nd:YAG laser application. Conclusion: Nd:YAG and IPL were successful with very low side-effect rates in a wide range of indications. Our study is the first evaluation of the efficacy of Nd:YAG and IPL combination therapy applied at 2-week intervals, and high efficiency was observed with no increase in any complication rate by intermittently combining different wavelengths.